|
1
|
Levey AS, Atkins R, Coresh J, Cohen EP,
Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, et
al: Chronic kidney disease as a global public health problem:
Approaches and initiatives-a position statement from kidney disease
improving global outcomes. Kidney Int. 72:247–259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schieppati A and Remuzzi G: Chronic renal
diseases as a public health problem: Epidemiology, social and
economic implications. Kidney Int Suppl. 98:S7–S10. 2005.
View Article : Google Scholar
|
|
3
|
Jacobson HR: Chronic renal failure:
Pathophysiology. Lancet. 338:419–423. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Luo X, Deng L, Lamsal LP, Xu W, Xiang C
and Cheng L: AMP-activated protein kinase alleviates extracellular
matrix accumulation in high glucose-induced renal fibroblasts
through mTOR signaling pathway. Cell Physiol Biochem. 35:191–200.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou X, Zhang J, Xu C and Wang W: Curcumin
ameliorates renal fibrosis by inhibiting local fibroblast
proliferation and extracellular matrix deposition. J Pharmacol Sci.
126:344–350. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eddy AA: Molecular insights into renal
interstitial fibrosis. J Am Soc Nephrol. 7:2495–2508.
1996.PubMed/NCBI
|
|
7
|
Ronco P and Chatziantoniou C: Matrix
metalloproteinases and matrix receptors in progression and reversal
of kidney disease: Therapeutic perspectives. Kidney Int.
74:873–878. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Basile DP, Fredrich K, Weihrauch D, Hattan
N and Chilian WM: Angiostatin and matrix metalloprotease expression
following ischemic acute renal failure. Am J Physiol Renal Physiol.
286:F893–F902. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Racca MA, Novoa PA, Rodríguez I, Della
Vedova AB, Pellizas CG, Demarchi M and Donadio AC: Renal
dysfunction and intragraft proMMP9 activity in renal transplant
recipients with interstitial fibrosis and tubular atrophy. Transpl
Int. 28:71–78. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou TB, Qin YH, Lei FY, Huang WF and
Drummen GP: Prohibitin attenuates oxidative stress and
extracellular matrix accumulation in renal interstitial fibrosis
disease. PLoS One. 8:e771872013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
DeCoux A, Lindsey ML, Villarreal F, Garcia
RA and Schulz R: Myocardial matrix metalloproteinase-2: Inside out
and upside down. J Mol Cell Cardiol. 77:64–72. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fine LG and Norman JT: Chronic hypoxia as
a mechanism of progression of chronic kidney diseases: From
hypothesis to novel therapeutics. Kidney Int. 74:867–872. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Norman JT, Orphanides C, Garcia P and Fine
LG: Hypoxia-induced changes in extracellular matrix metabolism in
renal cells. Exp Nephrol. 7:463–469. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Orphanides C, Fine LG and Norman JT:
Hypoxia stimulates proximal tubular cell matrix production via a
TGF-beta1-independent mechanism. Kidney Int. 52:637–647. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Fan R, Zhao S, Liu L, Guo S, Wu N,
Zhang W and Chen P: Reactive oxygen species released from hypoxic
hepatocytes regulates MMP-2 expression in hepatic stellate cells.
Int J Mol Sci. 12:2434–2447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bellot G, Garcia-Medina R, Gounon P,
Chiche J, Roux D, Pouysségur J and Mazure NM: Hypoxia-induced
autophagy is mediated through hypoxia-inducible factor induction of
BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol.
29:2570–2581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mazure NM and Pouysségur J:
Hypoxia-induced autophagy: Cell death or cell survival? Curr Opin
Cell Biol. 22:177–180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Michiels C: Physiological and pathological
responses to hypoxia. Am J Pathol. 164:1875–1882. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dada LA, Welch LC, Zhou G, Ben-Saadon R,
Ciechanover A and Sznajder JI: Phosphorylation and ubiquitination
are necessary for Na, K-ATPase endocytosis during hypoxia. Cell
Signal. 19:1893–1898. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kukulski W, Schorb M, Kaksonen M and
Briggs JA: Plasma membrane reshaping during endocytosis is revealed
by time-resolved electron tomography. Cell. 150:508–520. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim HN and Chung HS: Caveolin-1 inhibits
membrane-type 1 matrix metalloproteinase activity. BMB Rep.
41:858–862. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sato H, Takino T, Okada Y, Cao J,
Shinagawa A, Yamamoto E and Seiki M: Matrix metalloproteinase
expressed on the surface of invasive tumour cells. Nature.
370:61–65. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Butler GS, Butler MJ, Atkinson SJ, Will H,
Tamura T, van Schade Westrum S, Crabbe T, Clements J, d'Ortho MP
and Murphy G: The TIMP2 membrane type 1 metalloproteinase
‘receptor’ regulates the concentration and efficient activation of
progelatinase A.A kinetic study. J Biol Chem. 273:871–880. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
D'Amico G: Tubulo-interstitial damage in
glomerular diseases: Its role in the progression of the renal
damage. Nephrol Dial Transplant. 13:(Suppl 1). S80–S85. 1998.
View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takahara T, Furui K, Funaki J, Nakayama Y,
Itoh H, Miyabayashi C, Sato H, Seiki M, Ooshima A and Watanabe A:
Increased expression of matrix metalloproteinase-II in experimental
liver fibrosis in rats. Hepatology. 21:787–795. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tanaka S, Tanaka T and Nangaku M: Hypoxia
as a key player in the AKI-to-CKD transition. Am J Physiol Renal
Physiol. 307:F1187–F1195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Norman J and Orphanides C: Hypoxia alters
extracellular matrix (ECM) synthesis and turnover in renal
fibroblasts. J Am Soc Nephrol. 7:A25771996.
|
|
29
|
Chow AK, Cena J, El-Yazbi AF, Crawford BD,
Holt A, Cho WJ, Daniel EE and Schulz R: Caveolin-1 inhibits matrix
metalloproteinase-2 activity in the heart. J Mol Cell Cardiol.
42:896–901. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schnitzer JE, Oh P, Pinney E and Allard J:
Filipin-sensitive caveolae-mediated transport in endothelium:
Reduced transcytosis, scavenger endocytosis, and capillary
permeability of select macromolecules. J Cell Biol. 127:1217–1232.
1994. View Article : Google Scholar : PubMed/NCBI
|
